Michael Wolff, MD, was named the first master instructor for the Discseel procedure, a minimally invasive outpatient spine treatment.

New York City-based Hospital for Special Surgery launched a clinical trial that will evaluate the efficacy of concentrated bone marrow aspirate as an addition to ACL revision surgery.

Physicians at Carmel, N.Y.-based Somers Orthopaedic & Spine Surgery Center have performed the first autologous live stem cell knee injection. 

Hudson, Mass.-based surface coatings provider Precision Coating has tapped Eric Manojlović as its manager of orthopedic sales. 

Lenoss Medical closed an oversubscribed series A funding round of $4 million to help accelerate commercialization of its OsteoPearl spinal allograft. 

Tetrous' EnFix TAC demineralized bone fiber implants were used in their first cases, the company said May 8.

From funding to FDA clearances, here are six key developments in orthopedic regenerative medicine since March 7.

The University of California Los Angeles is part of a multi-institution research team that earned a contract of up to $33 million to develop treatments for joint regeneration for osteoarthritis.

Orthobiologics developer OssDesign has been awarded a contract with the U.S. Department of Veterans Affairs to provide products for an additional 100 VA hospitals nationwide, according to an April 29 report from Realtid.

Daniel Grande, PhD, was named president-elect of the International Cartilage Regeneration & Joint Preservation Society, according to an April 18 news release.

Regenerative therapeutics company Theradaptive has appointed Frank Vizesi, PhD, as its chief scientific officer. 

Regenerative medicine in spine surgery is an area of the field that still has room for research and growth. 

A man who was paralyzed seven years ago can walk and stand on his own after taking part in a stem cell study at Rochester, Minn.-based Mayo Clinic, ABC News reported April 1.

Cassandra Lee, MD, recently became one of the first surgeons in the U.S. to use the CartiHeal Agili-C cartilage repair implant.

SurGenTec's OsteoFlo hydroputty synthetic bone graft earned 510(k) clearance from the FDA, the medtech company said March 7.

Bone Biologics, a company focused on spine fusion products, recently announced a $2 million public offering.

In February, Zimmer Biomet closed on the acquisition of orthobiologics company Embody for $155 million. Embody focuses on soft tissue healing, and its portfolio includes the Tapestry biointegrative implant for tendon healing and Tapestry RC implant for rotator cuff repair.

Regenerative medicine has been growing in orthopedics, and there's one important element that can push it forward in the field.

Here are four biologics updates Becker's has reported on since Dec. 13:

RTI Surgical signed an agreement to acquire Cook Biotech, according to a Jan. 8 news release.